DAVID ALONSO: Open Payments
NPI 1467403246 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 32 payments from 15 companies in 2025. Trend: 2023 $1,292 · 2024 $690 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $205 |
| ABBVIE INC. | 6 | $129 |
| Novo Nordisk Inc | 2 | $50 |
| Corcept Therapeutics | 2 | $46 |
| PFIZER INC. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: BREZTRI, AIRSUPRA, CREON, Korlym, JOURNAVX, Wegovy, ZENPEP, OFEV.
Industry payments across CA — which companies pay providers there.
